As of 2025-05-15, the EV/EBITDA ratio of Healthlynked Corp (HLYK) is -2.06. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HLYK's latest enterprise value is 7.58 mil USD. HLYK's TTM EBITDA according to its financial statements is -3.68 mil USD. Dividing these 2 quantities gives us the above HLYK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.2x - 11.9x | 7.0x |
| Forward P/E multiples | 6.3x - 27.0x | 7.4x |
| Fair Price | (0.08) - (0.16) | (0.10) |
| Upside | -439.1% - -732.6% | -485.2% |
| Date | EV/EBITDA |
| 2024-11-05 | -2.45 |
| 2024-11-04 | -2.64 |
| 2024-11-01 | -2.64 |
| 2024-10-31 | -2.64 |
| 2024-10-30 | -2.53 |
| 2024-10-29 | -2.54 |
| 2024-10-28 | -2.71 |
| 2024-10-25 | -2.87 |
| 2024-10-24 | -2.83 |
| 2024-10-23 | -3.21 |
| 2024-10-22 | -2.96 |
| 2024-10-21 | -3.21 |
| 2024-10-18 | -3.22 |
| 2024-10-17 | -3.02 |
| 2024-10-16 | -3.04 |
| 2024-10-15 | -3.37 |
| 2024-10-14 | -2.73 |
| 2024-10-11 | -2.37 |
| 2024-10-10 | -2.45 |
| 2024-10-09 | -2.68 |
| 2024-10-08 | -3.14 |
| 2024-10-07 | -3.45 |
| 2024-10-04 | -3.13 |
| 2024-10-03 | -3.12 |
| 2024-10-02 | -3.23 |
| 2024-10-01 | -3.37 |
| 2024-09-30 | -3.45 |
| 2024-09-27 | -3.33 |
| 2024-09-26 | -3.37 |
| 2024-09-25 | -3.52 |
| 2024-09-24 | -3.60 |
| 2024-09-23 | -3.45 |
| 2024-09-20 | -3.45 |
| 2024-09-19 | -3.52 |
| 2024-09-18 | -3.92 |
| 2024-09-16 | -3.92 |
| 2024-09-13 | -3.95 |
| 2024-09-12 | -3.88 |
| 2024-09-11 | -3.88 |
| 2024-09-10 | -3.98 |
| 2024-09-09 | -4.05 |
| 2024-09-06 | -3.91 |
| 2024-09-05 | -4.18 |
| 2024-09-04 | -4.06 |
| 2024-09-03 | -4.16 |
| 2024-08-30 | -4.19 |
| 2024-08-29 | -4.18 |
| 2024-08-28 | -4.21 |
| 2024-08-27 | -4.18 |
| 2024-08-26 | -4.14 |